Trump announces deal with 9 new pharmaceutical firms in move to ease drug costs
Updated on: August 31, 2026 / 4:38 PM EDT / CBS News
TL;DR
- The Trump administration has signed agreements with nine new pharmaceutical firms.
- These agreements aim to offer discounted drugs to state Medicaid programs.
- The deals are projected to save Americans over $600 billion.
- This is part of the "most-favored-nation" drug pricing policy, aiming for U.S. prices comparable to other developed nations.
- Seventeen companies had previously agreed to lower drug prices voluntarily.
- The nine new firms are midsize pharmaceutical companies.
- The companies have also committed to spending $19.6 billion on manufacturing.
- Participating companies include Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB.